{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:34:36Z","timestamp":1740148476247,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12105-018-0937-z","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T06:36:15Z","timestamp":1527662175000},"page":"188-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ezrin\u2013Radixin\u2013Moesin Binding Phosphoprotein 50: A Potential Novel Biomarker in Human Papilloma Virus-Associated Head and Neck Squamous Cell Carcinomas"],"prefix":"10.1007","volume":"13","author":[{"given":"Athiva","family":"Shankar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy H.","family":"Crouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2734-0537","authenticated-orcid":false,"given":"Michaelina","family":"Macluskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"key":"937_CR1","unstructured":"Cancer Research UK. 2018. \n                    http:\/\/cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/oral-cancer\n                    \n                  . Accessed 22 Jan 2018."},{"key":"937_CR2","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1093\/annonc\/mdx304","volume":"28","author":"M Taberna","year":"2017","unstructured":"Taberna M, Mena M, Pav\u00f3n MA, Alemany L, Gillison ML, Mes\u00eda R. Human papillomavirus related oropharyngeal cancer. Ann Oncol. 2017;28:2386\u201398.","journal-title":"Ann Oncol"},{"key":"937_CR3","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1038\/onc.2016.462","volume":"36","author":"J Vaquero","year":"2017","unstructured":"Vaquero J, Nguyen Ho-Boldoires CA, Fouassier L. Role of the PDZ-scaffold protein NHERF1\/EBP50 in cancer biology: from signalling regulation to clinical relevance. Oncogene. 2017;36:3067\u201379.","journal-title":"Oncogene"},{"key":"937_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0002-9440(10)63944-2","volume":"158","author":"AO Stemmer-Rachamimov","year":"2001","unstructured":"Stemmer-Rachamimov AO, Wiederhold T, Nielsen GP, James M, Pinney-Michalowski D, Roy JE, et al. NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. Am J Pathol. 2001;158:57\u201362.","journal-title":"Am J Pathol"},{"key":"937_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1593\/neo.10780","volume":"12","author":"Y Hayashi","year":"2010","unstructured":"Hayashi Y, Molina JR, Hamilton SR, Georgescu M-M. NHERF1\/EBP50 is a new marker in colorectal cancer. Neoplasia. 2010;12:1013\u201322.","journal-title":"Neoplasia"},{"key":"937_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1053\/jhep.2003.50270","volume":"38","author":"T Shibata","year":"2003","unstructured":"Shibata T, Chuma M, Kokubu A, Sakamoto M, Hirohashi S. EBP50, a \u03b2-Catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 2003;38:178\u201386.","journal-title":"Hepatology"},{"key":"937_CR7","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.1158\/0008-5472.CAN-10-1271","volume":"70","author":"JR Molina","year":"2010","unstructured":"Molina JR, Morales FC, Hayashi Y, Aldape KD, Georgescu M-M. Loss of PTEN binding adapter protein NHERF1 from plasma membrane in Glioblastoma contributes to PTEN inactivation. Cancer Res 2010;70:6697\u2013703.","journal-title":"Cancer Res"},{"key":"937_CR8","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1038\/sj.onc.1210336","volume":"6","author":"EL Kreimann","year":"2007","unstructured":"Kreimann EL, Morales FC, de Orbeta-Cruz J, Takahashi Y, Adams H, Liu T-J, et al. Cortical stabilization of \u03b2-Catenin contributes to NHERF1\/EBP50 tumor suppressor function. Oncogene. 2007;6:5290\u201399.","journal-title":"Oncogene"},{"key":"937_CR9","doi-asserted-by":"publisher","first-page":"8208","DOI":"10.1128\/JVI.00114-11","volume":"85","author":"R Accardi","year":"2011","unstructured":"Accardi R, Rubino R, Scalise M, Gheit T, Shahzad N, Thomas M, et al. E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na\/H exchange regulatory factor 1. J Virol. 2011;85:8208\u201316.","journal-title":"J Virol"},{"key":"937_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/pathogens5010008","volume":"5","author":"CD James","year":"2016","unstructured":"James CD, Roberts S. Viral interactions with PDZ domain-containing proteins-an oncogenic trait? Pathogenes. 2016;5:8.","journal-title":"Pathogenes"},{"key":"937_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrc798","volume":"2","author":"H Zur Hausen","year":"2002","unstructured":"Zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer. 2002;2:42\u201350.","journal-title":"Nat Rev Cancer"},{"key":"937_CR12","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3892\/ijo.2016.3655","volume":"49","author":"Z Peng","year":"2016","unstructured":"Peng Z, Wang Q, Zhang Y, He J, Zheng J. EBP50 interacts with EGFR and regulates EGFR signalling to affect the prognosis of cervical cancer patients. Int J Oncol. 2016;49:1737\u201345.","journal-title":"Int J Oncol"},{"key":"937_CR13","doi-asserted-by":"publisher","first-page":"c2512","DOI":"10.1136\/bmj.c2512","volume":"340","author":"EJ Junor","year":"2010","unstructured":"Junor EJ, Kerr GR, Brewster DH. Oropharyngeal cancer. Fastest increasing cancer in Scotland, especially in men. Br Med J. 2010;340:c2512.","journal-title":"Br Med J"},{"key":"937_CR14","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","volume":"29","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294\u2013301.","journal-title":"J Clin Oncol"},{"key":"937_CR15","doi-asserted-by":"publisher","first-page":"6598","DOI":"10.1158\/0008-5472.CAN-16-0633","volume":"76","author":"AG Schache","year":"2016","unstructured":"Schache AG, Powell NG, Cuschieri KS, et al. HPV-Related oropharynx cancer in the United Kingdom: an evolution in the understanding of disease etiology. Cancer Res. 2016;76:6598\u2013606.","journal-title":"Cancer Res"},{"key":"937_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10552-017-0889-8","volume":"28","author":"P Javadi","year":"2017","unstructured":"Javadi P, Sharma A, Zahnd WE, Jenkins WD. Evolving disparities in the epidemiology of oral cavity and oropharyngeal cancers. Cancer Causes Control. 2017;28:635\u201345.","journal-title":"Cancer Causes Control"},{"key":"937_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12105-012-0369-0","volume":"6","author":"JS Lewis Jr","year":"2012","unstructured":"Lewis JS Jr. p16 immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol. 2012;6:75\u201382.","journal-title":"Head Neck Pathol"},{"key":"937_CR18","first-page":"646975","volume":"9","author":"S Begum","year":"2003","unstructured":"Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res. 2003;9:6469\u201375.","journal-title":"Clin Cancer Res"},{"key":"937_CR19","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.3892\/ol.2013.1271","volume":"5","author":"X-G Lv","year":"2013","unstructured":"Lv X-G, Lei X-F, Ji MY, Guo X-F, Wang J, Dong W-G. Clinical significance of EBP50 overexpression assessed by quantum dot analysis in gastric cancer. Oncol Lett. 2013;5:1844\u201348.","journal-title":"Oncol Lett"},{"key":"937_CR20","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/jnci\/82.18.1477","volume":"82","author":"RM Resnick","year":"1990","unstructured":"Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J, et al. Detection and typing of Human Papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst. 1990;82:1477\u201384.","journal-title":"J Natl Cancer Inst"},{"key":"937_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0166-0934(00)00194-4","volume":"88","author":"K Husnjak","year":"2000","unstructured":"Husnjak K, Grce M, Magdi\u0107 L, Paveli\u0107 K. Comparison of five different polymerase chain reaction methods for detection of Human Papillomavirus in cervical cell specimens. J Virol Methods 2000;88:125\u201334.","journal-title":"J Virol Methods"},{"key":"937_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0166-0934(93)90038-S","volume":"42","author":"LM Tieben","year":"1993","unstructured":"Tieben LM, ter Schegget J, Minnaar R, Bavinck JNB, Berkhout RJ, Vermeer BJ, et al. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods. 1993;42:265\u201379.","journal-title":"J Virol Methods"},{"key":"937_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12\u20139.","journal-title":"J Pathol"},{"key":"937_CR24","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1091\/mbc.e06-07-0617","volume":"18","author":"RA Cardone","year":"2007","unstructured":"Cardone RA, Bellizzi A, Busco G, Weinman EJ, Dell\u2019Aquila ME, Casavola V, et al. The NHERF11 PDZ2 domain regulates PKA\u2013RhoA\u2013p38-mediated Nhe1 activation and invasion in breast tumor cells. Mol Biol Cell. 2007;18:1768\u201380.","journal-title":"Mol Biol Cell"},{"key":"937_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1365-2559.2009.03424.x","volume":"55","author":"A Mangia","year":"2009","unstructured":"Mangia A, Chiriatti A, Bellizzi A, Malfettone A, Stea B, Zito FA, et al. Biological role of NHERF1 protein expression in breast cancer. Histopathology. 2009;55:600\u201308.","journal-title":"Histopathology"},{"key":"937_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.yexmp.2012.03.004","volume":"92","author":"A Malfettone","year":"2012","unstructured":"Malfettone A, Silvestris N, Paradiso A, Mattioli E, Simone G, Mangia A. Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype. Exp Mol Pathol. 2012;92:296\u2013303.","journal-title":"Exp Mol Pathol"},{"key":"937_CR27","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1172\/JCI45661","volume":"122","author":"Y-Y Lin","year":"2012","unstructured":"Lin Y-Y, Hsu Y-H, Huang H-Y, et al. Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and \u03b2-catenin interactions. J Clin Investig. 2012;122:1881\u201394.","journal-title":"J Clin Investig"},{"key":"937_CR28","doi-asserted-by":"publisher","first-page":"e904","DOI":"10.1038\/cddis.2013.439","volume":"4","author":"A Paradiso","year":"2013","unstructured":"Paradiso A, Scarpi E, Malfettone A, Addati T, Giotta F, Simone G, et al. Nuclear NHERF1 expression as a prognostic marker in breast cancer. Cell Death Dis. 2013;4:e904.","journal-title":"Cell Death Dis"},{"key":"937_CR29","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1038\/sj.onc.1202920","volume":"18","author":"D Gardiol","year":"1999","unstructured":"Gardiol D, K\u00fchne C, Glaunsinger B, Lee SS, Javier R, Banks L. Oncogenic Human Papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene. 1999;18:5487\u201396.","journal-title":"Oncogene"},{"key":"937_CR30","doi-asserted-by":"publisher","first-page":"8244","DOI":"10.1128\/MCB.20.21.8244-8253.2000","volume":"20","author":"S Nakagawa","year":"2000","unstructured":"Nakagawa S, Huibregtse JM. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol. 2000;20:8244\u201353.","journal-title":"Mol Cell Biol"},{"key":"937_CR31","doi-asserted-by":"publisher","first-page":"8033","DOI":"10.1038\/sj.onc.1207977","volume":"23","author":"P Massimi","year":"2004","unstructured":"Massimi P, Gammoh N, Thomas M, Banks L. HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation. Oncogene. 2004;23:8033\u201339.","journal-title":"Oncogene"},{"key":"937_CR32","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1128\/JVI.01756-10","volume":"85","author":"C Kranjec","year":"2011","unstructured":"Kranjec C, Banks L. A systematic analysis of Human Papillomavirus (HPV) E6 PDZ substrates identifies Magi-1 as a major target of HPV Type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions. J Virol. 2011;85:1757\u201364.","journal-title":"J Virol"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-018-0937-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12105-018-0937-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-018-0937-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T11:56:50Z","timestamp":1567771010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12105-018-0937-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["937"],"URL":"https:\/\/doi.org\/10.1007\/s12105-018-0937-z","relation":{},"ISSN":["1936-0568"],"issn-type":[{"type":"electronic","value":"1936-0568"}],"subject":[],"published":{"date-parts":[[2018,5,30]]},"assertion":[{"value":"6 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Tayside Tissue Bank (TR000325), was conducted according to the guidelines outlined by the Research Governance Framework in Tayside, Scotland and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"For this type of study, formal consent was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}